secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2023-07-21T23:59:59+00:00
Accession:  0001104659-23-083082
Event type: regulatory
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq grants Avenue Therapeutics extension to Nov 15, 2023 for stockholders' equity compliance
--------------------------------------------------------------------------------

- Nasdaq Staff granted extension until November 15, 2023 to regain compliance with minimum $2.5M stockholders' equity rule.
- Company originally notified of deficiency on May 19, 2023 for not meeting Nasdaq Listing Rule 5550(b)(1).
- Company intends to work diligently to regain compliance but cannot assure success.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000110465923083082/0001104659-23-083082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000110465923083082/tm2321816d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-083082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer